The Director appoints the members of the council, to be made up of 
8 scientists not working directly on DNA Recombinants plus 4 representa- 
tives of the public at large. The 8 scientists will be drawn from leaders 
in related fields of biomedical research (such as genetics, bacteriology, 
virology, botany, infectious diseases, public health, etc. ) and the 4 
non- scientists from leaders in areas of public concern (such as bioethics, 
law, sociology, medical history, etc. ). 
Each institution receiving NIH funds will be required to 
appoint a local committee on biohazards, which will be expected to become 
familiar with the Recombinant DNA Safety Regulations promulgated by the 
NIH Technical Committee and approved by the Advisory Council. No 
research grant or contract will be considered by NIH in the area of 
Recombinant DNA unless the local committee certifies, to the satisfaction 
of the Technical Committee or its designee, that the principal investigator 
► 
and the local institution meet these Safety Regulations. If the grant is 
v 
awarded, the local committee will periodically inspect the laboratory of 
* 
the principal investigator and submit an annual report of these inspections 
to NIH to assure that the Regulations are being carried out. 
Except when the Technical Committee is considering Applications 
for Research Grants, its meetings shall be open to the public. Time will 
be provided to hear the opinions of scientists and non- scientists who 
feel that the regulations should be modified. These discussions will be 
summarized and evaluated by the Technical Committee for consideration 
by the Advisory Council. 
[ 448 ] 
